Advertisement
In a population of predominantly young

Low Adherence to Daily HIV Prophylaxis in High-Risk Women

0
Products that do not require daily use may be more suitable for some women
Researchers say giving birth control information to women visiting dermatology clinics can help promote the safe use of isotretinoin. The study was published online Feb. 4 in JAMA Dermatology.

Contraception Info Given With Isotretinoin Rx Ups Safe Use

0
Effective birth control key in using the medication
The tragic shooting of surgeon Michael Davidson can be used as an opportunity to find meaning in tragedy

Perspective on Dr. Davidson: ‘Be Like Mike’

0
Michael Davidson took on highest risk patients, sought to extend lives in cases deemed 'hopeless'
Scientists say they have identified two new genetic variants that are associated with an increased risk of breast cancer. Their findings are published online Feb. 4 in Human Molecular Genetics.

Two Novel Genetic Variants for Breast Cancer Discovered

0
London scientists say variants most strongly linked to estrogen receptor-positive disease
Menstrual abnormalities

Chronic Fatigue Syndrome Linked With Earlier Surgical Menopause

0
Menstrual abnormalities, endometriosis, pelvic pain also associated with CFS
Fewer than half of Americans are aware that some major lifestyle factors can affect their cancer risk

AICR: Awareness of Key Cancer Risk Factors Alarmingly Low

0
Many worry about unproven factors like food additives; less about exercise and obesity
If more women had access to modern birth control methods and used them correctly

Debunking Contraception Myths to Reduce Unintended Pregnancy

0
Study of 35 nations shows underuse of current contraception options
Although fewer Americans are smoking and more communities have smoke-free laws

Secondhand Smoke Exposure Down But Still Too High

0
Two out of five children breathing in secondhand smoke
Lung cancer has overtaken breast cancer as the leading cancer killer of women in developed countries

Lung Cancer Now Leads Cancer Mortality in Developed Nations

0
Leading cancer killer of American women for many years
Ibrance (palbociclib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer among postmenopausal women.

FDA Approves Ibrance to Treat Advanced Breast Cancer

0
For postmenopausal women with ER+, HER2− metastatic breast cancer